Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
JENBURKT PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 23.3322.2121.9818.1516.61

What is the latest Core EBITDA Margin ratio of JENBURKT PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of JENBURKT PHARMACEUTICALS is 23.33 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar202423.33
Mar202322.21
Mar202221.98
Mar202118.15
Mar202016.61

How is Core EBITDA Margin of JENBURKT PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2024 23.33
5.04
Mar2023 22.21
1.05
Mar2022 21.98
21.10
Mar2021 18.15
9.27
Mar2020 16.61 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹551.3 Cr 23.7% 20.8% 107.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,604.0 Cr 0.1% -4% 52.9% Stock Analytics
DIVIS LABORATORIES ₹157,639.0 Cr 0.7% -0% 70.9% Stock Analytics
CIPLA ₹128,549.0 Cr 0.5% -1.7% 29.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,956.0 Cr 1.1% -2.6% 19.2% Stock Analytics
ZYDUS LIFESCIENCES ₹97,468.9 Cr -3.6% -8.4% 62.9% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

23.7%

20.8%

107.5%

SENSEX

-0.3%

-2.4%

22.4%


You may also like the below Video Courses